BINX HEALTH LIMITED

1. BINX HEALTH LIMITED 2018-10-05 → present
2. ATLAS GENETICS LIMITED 2005-07-19 → 2018-10-05

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

IFRS

Reporting scope

Consolidated group

Auditor

Grant Thorton UK LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The Group and the Parent Company have incurred recurring losses since inception... Given the support available the Directors are confident of the Group and the Parent Company's ability to continue as a going concern for a period of at least 12 months from the date of approval of these consolidated and Parent Company financial statements. They consider that there will be sufficient funding available based on ongoing discussions with investors and therefore have determined that the going concern basis in the preparation of these financial statements is still appropriate.”

Group structure

1. BINX HEALTH LIMITED · parent
   1. binx health, Inc. 100% · Delaware, USA · to support commercialization of the Group's products in the U.S.

Significant events

• “The Group completed additional tranches of Series F financing in 2024 raising $25,000 from existing investors. In April and May of 2025, the Group raised an additional $6,500 series F financing.”
• “In April 2024 the Group, entered into up to $25,000 equipment lease agreement with CSC leasing company ("CSC") and drew down $3,808 through this facility.”
• “In October 2024 existing binx shareholders purchased the loan payable that binx had with related party Orbimed Royalty and Credit Opportunities III, LP ("Orbimed").”
• “During 2024, a majority of the Company's shares were acquired by Hildred Capital Management II, LP (Hildred Capital), As a result, the new ultimate controlling party of the Group and ultimate beneficial owner at year end is was Hildred Capital.”
• “In December 2023, the Group sold its binx everywhere product in order to focus the Group's efforts on the point of care io solution discussed above.”
• “On January 6, 2025 the Group has entered into a $25,000 debt facility with Kreos Capital VII (UK) Limited and received first tranche of $12,500 of cash. In conjunction with the new debt facility the loan payable to investors was converted to series F shares. In April and May of 2025, the Group raised additional $6,500 series F financing in series F.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

10

last 12 months

Capital events

5

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +132.3%

  £1,127,502 → £2,618,977

• Cash

  -84.2%

  £8,198,666 → £1,292,809

• Net assets

  -88.4%

  -£103,827,279 → -£195,597,480

• Employees

  -24.7%

  93 → 70

• Operating profit

  -1.4%

  -£26,279,466 → -£26,650,852

• Profit before tax

  -364.5%

  £36,163,084 → -£95,664,937

• Wages

  -14.4%

  £11,080,059 → £9,481,838

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers